Mankind Pharma Adjusts Evaluation Amid Strong Operational Performance and Market Dynamics

Jan 13 2025 07:31 PM IST
share
Share Via
Mankind Pharma has recently experienced a change in evaluation, reflecting a thorough analysis of its financial metrics and market conditions. The company has demonstrated strong management efficiency, consistent operational results, and a positive technical outlook, alongside a notable increase in institutional holdings.
Mankind Pharma, a notable entity in the pharmaceuticals and drugs sector, has recently undergone an adjustment in evaluation. This revision reflects a comprehensive analysis of various financial metrics and market dynamics that influence the company's standing.

The company has consistently showcased strong management efficiency, highlighted by a return on equity (ROE) of 19.25% and a notably low debt-to-equity ratio. Mankind Pharma has achieved positive operational results over six consecutive quarters, with operating cash flow reaching Rs 2,152.45 crore and net sales amounting to Rs 3,076.51 crore. Furthermore, the profit before depreciation, interest, and taxes (PBDIT) has also reached a significant level at Rs 850.04 crore.

From a technical perspective, the stock is positioned within a mildly bullish range, with the On-Balance Volume (OBV) indicator indicating positive trends since early January 2025. Institutional holdings are reported at 22.27%, reflecting a slight increase from the previous quarter. Despite a notable return over the past year and a substantial rise in profits, the stock's valuation appears elevated, as evidenced by a price-to-book value of 10.1.

For those interested in further insights, Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News